About the Study
Migraine is a chronic and debilitating disorder that affects approximately 15% of the population. Migraines are characterized by recurrent attacks lasting 4 to 72 hours with multiple symptoms, including pulsating (throbbing) headaches of moderate to severe pain that could be associated with nausea or vomiting, and/or sensitivity to sound (phonophobia) and sensitivity to light (photophobia).
The purpose of the research study is to determine the effectiveness of rimegepant as a preventive treatment for migraine. This is measured by counting the number of migraine days you have each month.
This is a research study to test a new investigational medication.
- Rimegepant is being developed for the treatment of migraine
- All Lab Results, ECG Reports, Physician Visits, and Study Medications will be provided at no cost to you
- A copy of your Lab Results and ECG Reports will be provided to you per your request again free of charge
All participants will be compensated for their time, travel and compliance to be part of the clinical study.
The compensation can go up-to a total of more than $1000